Narrow Indication for Abuse-Deterrent Morphine

The latest opioid approved by FDA will be “expected” to reduce abuse by only one route — injection — in its official labeling.

In a carefully-worded press release, drugmaker Egalet said its extended-release morphine drug Arymo ER “increased resistance to cutting, crushing, grinding or breaking using a variety of tools. Due to its physical and chemical properties, Arymo ER is expected to make abuse by injection difficult.” 1pillst

In an FDA advisory committee meeting last year, participants voted that the drug could deter abuse via the oral, nasal, and intravenous routes of abuse. But there were several reasons only the intravenous route won labeling.

An FDA spokesperson told MedPage Today that MorphaBond, another morphine product, has “marketing exclusivity for labeling describing the expected reduction of abuse of single-entity, extended-release morphine by the intranasal route due to physicochemical properties.” MORE HERE

Advertisements

About RichardB

I am trained and work as a Creative Arts Therapist. I have passionately studied, worked, and taught as a hands on practitioner of the Creative/Expressive and Healing Arts since 1983. I have integrated training’s in modalities which include Swedish Massage, Jin Shin Do, Trager Work, Hatha Yoga, Gestalt Therapy, Halprin Method, Group Creative Arts Therapy, Tai Chi, Meditation, Motional Processing, Rituals, Interfaith Celebrations, Progressive Early Childhood and Adult Education, Addiction and Recovery Services, Counseling and Psychotherapy, Dance/Movement Therapy. I currently provide Creative Arts and Counseling services to a local nonprofit agency as well as teaching local classes and workshops. I use compassion and acceptance to create an environment that is safe and nurturing for individual clients and/or groups.
This entry was posted in Addiction, Opioids, Pain, research, Substance use and tagged , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s